Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$57,724,920
+$14,854,864 QoQ
Shares Held
62,219
+6.0% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#57
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. ARGX ranks #33 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,724,920 | 62,219 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $42,870,056 | 58,706 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $54,025,990 | 64,244 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $51,445,546 | 69,751 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $34,689,376 | 62,932 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $31,029,114 | 52,426 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $33,288,720 | 54,128 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $20,566,514 | 37,940 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $15,621,632 | 36,326 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $13,475,853 | 34,227 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $11,922,674 | 31,340 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,633,734 | 39,936 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,032,866 | 28,309 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,129,694 | 21,820 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,985,735 | 21,080 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,064,367 | 22,842 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,989,442 | 21,087 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,158,154 | 16,359 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,922,412 | 16,912 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $4,181,190 | 13,845 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,761,127 | 22,457 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,195,053 | 29,758 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $7,779,561 | 26,453 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $6,946,539 | 26,461 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,403,695 | 19,552 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $2,239,805 | 17,003 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||